Information

Website

View here

Description in French

TrophiPatch est un patch cutané intégrant des cellules souches vivantes issues du tissu adipeux, activées pour restaurer la vascularisation des plaies chroniques résistantes. Contrairement aux traitements actuels qui visent uniquement la fermeture de la plaie, TrophiPatch cible la cause principale de l’échec de cicatrisation : la détérioration vasculaire. Cette approche régénérative, innovante, vise à relancer la cicatrisation et réduire le risque d’amputation. Un essai clinique de phase I/II est en cours aux HUG.

Description in English

TrophiPatch is a living skin patch embedding activated adipose-derived stem cells that restore vascular function in chronic, treatment-resistant wounds. Unlike current therapies that mainly focus on wound closure, TrophiPatch addresses the root cause of impaired healing: insufficient blood supply. By regenerating damaged vessels, this approach aims to restart tissue repair and reduce the risk of amputation. A Phase I/II clinical trial sponsored by Geneva University Hospitals is currently ongoing.

Present

HealthTech | Thursday, March 12